Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations

      Influenza vaccination can reduce hospitalization rates by approximately 40% for those individuals deemed to be at high risk.
      To read this article in full you will need to make a payment


        • Muller L.M.
        • Gorter K.J.
        • Hak E.
        • et al.
        Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.
        Clin Infect Dis. 2005; 41: 281-288
        • Groenwold R.H.
        • Hoes A.W.
        • Hak E.
        Impact of influenza vaccination on mortality risk among the elderly.
        Eur Respir J. 2009; 34: 56-62
        • Jain S.
        • Kamimoto L.
        • Bramley A.M.
        • et al.
        Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009.
        N Engl J Med. 2009; 361: 1935-1944
        • Campbell A.
        • Rodin R.
        • Kropp R.
        • et al.
        Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.
        CMAJ. 2010; 182: 349-355
        • Vamos E.P.
        • Pape U.J.
        • Curcin V.
        • et al.
        Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.
        CMAJ. 2016; 188: E342-E351
        • Allard R.
        • Leclerc P.
        • Tremblay C.
        • et al.
        Diabetes and the severity of pandemic influenza A (H1N1) infection.
        Diabetes Care. 2010; 33: 1491-1493
        • Lau D.
        • Eurich D.T.
        • Majumdar S.R.
        • et al.
        Working-age adults with diabetes experience greater susceptibility to seasonal influenza: A population-based cohort study.
        Diabetologia. 2014; 57: 690-698
        • Nichol K.L.
        • Nordin J.D.
        • Nelson D.B.
        • et al.
        Effectiveness of influenza vaccine in the community-dwelling elderly.
        N Engl J Med. 2007; 357: 1373-1381
        • Wang I.K.
        • Lin C.L.
        • Chang Y.C.
        • et al.
        Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study.
        Vaccine. 2013; 31: 718-724
        • Lau D.
        • Eurich D.T.
        • Majumdar S.R.
        • et al.
        Effectiveness of influenza vaccination in working-age adults with diabetes: A population-based cohort study.
        Thorax. 2013; 68: 658-663
        • Looijmans-Van den Akker I.
        • Verheij T.J.
        • Buskens E.
        • et al.
        Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients.
        Diabetes Care. 2006; 29: 1771-1776
        • Kornum J.B.
        • Thomsen R.W.
        • Riis A.
        • et al.
        Diabetes, glycemic control, and risk of hospitalization with pneumonia: A population-based case-control study.
        Diabetes Care. 2008; 31: 1541-1545
        • Fisman D.N.
        • Abrutyn E.
        • Spaude K.A.
        • et al.
        Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
        Clin Infect Dis. 2006; 42: 1093-1101
        • Government of Canada
        Canadian immunization guide: Part 4—active vaccines.
        Public Health Agency of Canada, Toronto (ON)2016 (Accessed November 15, 2017)
        • Kobayashi M.
        • Bennett N.M.
        • Gierke R.
        • et al.
        Intervals between PCV13 and PPSV23 vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2015; 64: 944-947
        • Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices
        Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
        MMWR Morb Mortal Wkly Rep. 2010; 59: 1102-1106
        • Mittal S.
        • El-Serag
        Epidemiology of HCC: Consider the population.
        J Clin Gastroenterol. 2013; 47: S2-S6
        • Parkin D.M.
        The global health burden of infection-associated cancers in the year 2002.
        Int J Cancer. 2006; 118: 3030-3044
        • Chang M.H.
        • Chen C.J.
        • Lai M.S.
        • et al.
        Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
        N Engl J Med. 1997; 336: 1855-1859
        • Reilly M.L.
        • Schillie S.F.
        • Smith E.
        • et al.
        Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus.
        J Diabetes Sci Technol. 2012; 6: 858-866
        • Thompson N.D.
        • Barry V.
        • Alelis K.
        • et al.
        Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County.
        J Am Geriatr Soc. 2010; 58: 914-918
        • Thompson N.D.
        • Schaefer M.K.
        “Never events”: Hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009–2010.
        J Diabetes Sci Technol. 2011; 5: 1396-1402
        • Williams I.T.
        • Perz J.F.
        • Bell B.P.
        Viral hepatitis transmission in ambulatory health care settings.
        Clin Infect Dis. 2004; 38: 1592-1598
        • Centers for Disease Control and Prevention (CDC)
        Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term–care facilities—Mississippi, North Carolina, and Los Angeles County, California, 2003–2004.
        MMWR Morb Mortal Wkly Rep. 2005; 54: 220-223
        • Centers for Disease Control and Prevention (CDC)
        Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1709-1711
        • Gnann Jr, J.W.
        • Whitley R.J.
        Clinical practice. Herpes zoster.
        N Engl J Med. 2002; 347: 340-346
        • Guignard A.P.
        • Greenberg M.
        • Lu C.
        • et al.
        Risk of herpes zoster among diabetics: A matched cohort study in a US insurance claim database before introduction of vaccination, 1997–2006.
        Infection. 2014; 42: 729-735
        • Gagliardi A.M.Z.
        • Silva B.N.G.
        • Torloni M.R.
        • et al.
        Vaccines for preventing herpes zoster in older adults.
        Sao Paulo Med J. 2014; 132: 255
        • Ke C.C.
        • Lai H.C.
        • Lin C.H.
        • et al.
        Increased risk of herpes zoster in diabetic patients comorbid with coronary artery disease and microvascular disorders: A population-based study in Taiwan.
        PLoS ONE. 2016; 11: e0146750
        • Canadian Pain Society Study Day participants
        Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 update and consensus statement from the Canadian Pain Society.
        Pain Res Manag. 2015; 20: 46-47
        • Moutschen M.P.
        • Scheen A.J.
        • Lefebvre P.J.
        Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.
        Diabete Metab. 1992; 18: 187-201
        • Heymann A.D.
        • Chodick G.
        • Karpati T.
        • et al.
        Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in Israel.
        Infection. 2008; 36: 226-230
        • Okamoto S.
        • Hata A.
        • Sadaoka K.
        • et al.
        Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.
        J Infect Dis. 2009; 200: 1606-1610
        • Hales C.M.
        • Harpaz R.
        • Ortega-Sanchez I.
        • et al.
        Update on recommendations for use of herpes zoster vaccine.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 729-731
        • An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
        Update on the use of herpes zoster vaccine.
        Public Health Agency of Canada, Toronto2014 (Accessed November 15, 2017)
        • Gagliardi A.M.
        • Andriolo B.N.
        • Torloni M.R.
        • et al.
        Vaccines for preventing herpes zoster in older adults.
        Cochrane Database Syst Rev. 2016; (CD008858)
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.
        PLoS Med. 2009; 6 (e1000097)